Abbott to sell part of testing unit to GE (Chicago Tribune)
Most of 4,000 workers expected to keep jobs Abbott Laboratories on Thursday agreed to sell a large part of its diagnostic test-making business to General Electric Co. for $8.13 billion in cash.

ThermoGenesis Corp. to Present at International Stem Cells and Regenerative Medicine 2007 Meeting (PR Newswire via Yahoo! Finance)
ThermoGenesis Corp. , a company that develops and markets enabling technologies for cord blood stem cell therapy and surgical wound care, announced today that Mr. Philip H. Coelho, the Company's Chairman and Chief Executive Officer, will be a featured speaker at the International Stem Cells and Regenerative Medicine 2007 meeting to be held January 22-24, 2007 in San Francisco, California.

Barr Receives Tentative Approval for Generic KYTRIL(R) Tablets, 1mg (Base) (FinanzNachrichten)
WOODCLIFF LAKE, N.J., Jan. 18 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, ( Nachrichten ) Inc. today announced that its subsidiary, Barr Laboratories, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Roche Laboratories Inc.'s KYTRIL(R) (granisetron hydrochloride) Tablets, 1mg (base).